Pharma channel feed

FDA grants Ve­rastem first ap­proval for rare ovar­i­an can­cer treat­ment

6 days ago
FDA+

FDA will con­vene vac­cine ad­vi­sors to dis­cuss Covid strain up­dates

Last week
FDA+

Gilead re­veals plans to put an­oth­er $11B in­to US man­u­fac­tur­ing

Last week
R&D
Manufacturing

Te­va plans staff cuts as it com­mits to ac­cel­er­at­ing growth

Last week
Manufacturing

PhRMA says tar­iffs are 'not the an­swer' as in­dus­try trade probe clos­es for com­ments

Last week
Manufacturing

FDA's ODAC will re­view drugs for four dif­fer­ent can­cers at meet­ing in May

Last week
FDA+

Avadel can pur­sue la­bel ex­pan­sion for nar­colep­sy drug Lum­ryz af­ter court rul­ing

Last week
Law

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

Last week

Com­pounders just lost their case to put obe­si­ty drug tirzepatide back in short­age

Last week
Law
Health Tech

What Vinay Prasad means for CBER, vac­cines, drug ap­provals and more

Last week
FDA+

No­vo Nordisk trims growth fore­cast as GLP-1 com­pounder ban yet to go live

Last week

Sarep­ta’s stock plum­mets af­ter Prasad ap­point­ment, low Ele­v­idys sales

Last week
FDA+

States sue US over plan for re­or­ga­ni­za­tion of fed­er­al health agen­cies

Last week
Law

Trump, Con­gress look at match­ing some US drug prices to costs abroad

Last week

Trump, FDA ze­ro in on for­eign fac­to­ries to give do­mes­tic sites an edge  

Last week
FDA+
Manufacturing

Eu­rope pledges €500M to at­tract glob­al sci­ence tal­ent

Last week
People

Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx

Last week

New opi­oid da­ta may not be gen­er­al­iz­able, FDA ad­comm says

Last week
FDA+

FDA ad­comm will re­view Capri­cor's cell ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy

Last week
Cell/Gene Tx
FDA+

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

Last week
People

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

Last week
R&D
FDA+

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

Last week
FDA+

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

Last week
R&D
FDA+

Miss­ing REMS de­lays Cy­to­ki­net­ic­s' heart drug PDU­FA, stock drops

Last week
FDA+
First page Previous page 12345 Next page Last page
A service from the Financial Times